Lord, Abbett & Co
CDLX icon

Lord, Abbett & Co’s Cardlytics CDLX Stock Holding History

Lord, Abbett & Co’s Portfolio CDLX Stock Details CDLX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-50,662
Closed -$64.3M – 646
2021
Q2 		$64.3M Sell
50,662
-35,115
-41% -$39.6M 0.16% 199
2021
Q1 		$94.1M Buy
85,777
+7,727
+10% +$10.2M 0.24% 124
2020
Q4 		$111M Buy
78,050
+21,758
+39% +$23.2M 0.29% 101
2020
Q3 		$39.7M Buy
56,292
+27,261
+94% +$19.8M 0.13% 254
2020
Q2 		$20.3M Sell
29,031
-5,490
-16% -$3.17M 0.07% 368
2020
Q1 		$12.1M Buy
34,521
+10,373
+43% +$7.35M 0.05% 394
2019
Q4 		$15.2M Buy
+24,148
New +$11.8M 0.05% 443

Other funds holding CDLX

CIP
CAS Investment Partners Westport, Connecticut $1.75B AUM 41.95% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
ACM
Alua Capital Management New York $1.13B AUM 8.41% 1-Year Est. Return
KGAMU
KPS Global Asset Management (UK) London, United Kingdom $620M AUM 14.15% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Lord, Abbett & Co's CDLX Position: Q3 2021 in Review

Lord, Abbett & Co sold out of Cardlytics (CDLX) in Q3 2021, closing a stake of 50,662 shares — an estimated $64.3M sold.

Lord, Abbett & Co first reported a position in CDLX in Q4 2019 and held it in 7 quarters. The position peaked at $111M in Q4 2020. 164 funds tracked by Wall St. Rank hold CDLX as of Q3 2021.

  • Lord, Abbett & Co reported no remaining Cardlytics position as of Q3 2021 after selling out during the quarter.
  • Lord, Abbett & Co sold 50,662 Cardlytics shares in Q3 2021, an estimated $64.3M.
  • Lord, Abbett & Co first reported a position in Cardlytics in Q4 2019 and held it in 7 quarters.
  • Lord, Abbett & Co's Cardlytics position peaked at $111M in Q4 2020.
  • 164 funds tracked by Wall St. Rank held Cardlytics as of Q3 2021.

Based on Lord, Abbett & Co's 13F filing for Q3 2021, filed 9 Nov 2021.